Q: What’s your outlook on this stock ?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I believe in the past you have suggest a maximum amount of a portfolio that would be allocated to a single fund company. I have generally tried to target 15% max with any single fund company, but haven't been able to find where I originally came up this value. Is this a reasonable split or unnecessarily cautious? I currently hold ETF's from BMO, Vanguard, iShares, and Global X (formerly Horizons).
Q: I’ve seen a lot of commentary online about HIMS. Can I get your opinion on this stock and whether it is hype or whether there is good potential here.
Q: Could provide any insight into why SVI has dropped hard in the last six weeks, down approximately 24%. Is this a buying opportunity or a falling knife?
Thank you, Mike
Thank you, Mike
Q: Could you please provide street estimates for Brookfield Corp, earnings.
Thank You
Thank You
Q: Can you advise what has happen with this stock? It looks like it has been halted from trading. I realized that here has been a merger of some kind so maybe this has affected the stock. Many tnx.
Q: what is your take concerning the plan of arrangement proposed by BEPC
Q: Which business do you have more confidence in over the next five years? I have smaller positions in both and would like to merge into one.
Thanks
Thanks
Q: Hi 5i Aurinia pharma seems to have turned the corner with earnings and is also getting the drug into hospitals They are again reducing staff this time by 45%. They also have a new drug in trails. Please put on your speculative hat for the questions.
-would drug (Lupkynis) be of interest at this stage in development for another company to buy them and what would the buyout price be for the right company.
-going forward they will make about $220,000,000 a year this took about 3 1/2 years with a covid launch, what do you see max sale's being with the current set up and how many years to get there.
-Do you think Aurinia is a good speculative buy.
Thank you for your service!
-would drug (Lupkynis) be of interest at this stage in development for another company to buy them and what would the buyout price be for the right company.
-going forward they will make about $220,000,000 a year this took about 3 1/2 years with a covid launch, what do you see max sale's being with the current set up and how many years to get there.
-Do you think Aurinia is a good speculative buy.
Thank you for your service!
Q: Hello 5i
Can you talk about the insider ownership of WELL and the major holders of the shares please ?
And why are CIBC World Markets' expectations of $5.25 on 08/11/2024 so low?
Thanks
Can you talk about the insider ownership of WELL and the major holders of the shares please ?
And why are CIBC World Markets' expectations of $5.25 on 08/11/2024 so low?
Thanks
Q: While questions on FOUR go back to its going public over 4 years ago, you recently seem to have become more bullish on the company. Is that because it has become profitable or are there other reasons? The payment space appears to be very competitive and I wonder what FOUR has that the others didn't or don't have. Finally, your data source lists it as a tech stock but in previous answers, you suggest it is a financial stock. Do you have strong feelings as to its classification?
Appreciate your insight.
Paul F.
Appreciate your insight.
Paul F.
-
Kraken Robotics Inc. (PNG)
-
Galaxy Digital Holdings Ltd. ordinary shares (GLXY)
-
Propel Holdings Inc. (PRL)
Q: Given our best guesses of what Trump 2.0 is likely to mean….three best Canadian small cap ideas please.
Q: Pretty nice earnings, but with other issues noted on previous questions what fair value would you place on the shares at this point?
Q: Comments please on the latest quarter and guidance from FOUR.
Thanks
Rob
Thanks
Rob
Q: What is your view of the infrastructure sector going forward? What is your view of IFRA? Would Jacobs be a better way to get exposure to the sector, or is there another investment you would suggest? About IFRA, there is a reference to it trading on CBOE, I am not familiar with this, can you explain what that is about? Many thanks
-
BMO MSCI Emerging Markets Index ETF (ZEM)
-
iShares Core MSCI EAFE IMI Index ETF (XEF)
-
iShares Core S&P U.S. Total Market Index ETF (XUU)
-
iShares Core S&P/TSX Capped Composite Index ETF (XIC)
Q: This is a follow up question to my previous question about using ETFs instead of stocks.
You mentioned that ZEM was “fine,“ whereas your comment on XEF is “solid,” XUU “we like it quite a lot,” and XIC is a “go-to.”
Do you have an alternative to ZEM that you would consider to be better? If so, please explain why.
You mentioned that ZEM was “fine,“ whereas your comment on XEF is “solid,” XUU “we like it quite a lot,” and XIC is a “go-to.”
Do you have an alternative to ZEM that you would consider to be better? If so, please explain why.
-
Enbridge Inc. (ENB)
-
TC Energy Corporation (TRP)
-
Pembina Pipeline Corporation (PPL)
-
South Bow Corporation (SOBO)
Q: Please rank if purchased at current prices.
TIA
TIA
Q: Hi Peter & team - I've seen you, and others, say there is still lots of money "parked on the sidelines". How do you know this? Where is it parked? And how do you know it will be deployed in the market? Thank you!
Q: I've noticed you do not have any covered call ETFs in your income portfolio. If not appropriate in your minds, are there any good situations for this type of investment, and if so, when? What are the PROs amd CONS? What are the better strategies or alternatives?
Q: On Monday morning it was at 29 dollars and now Wednesday morning it is at 22.70. There was no news. Im assuming it was because of Trumps tariff plans. Do you believe this is an over reaction and a good buying opportunity especially after the impressive release of q3.